[PDF][PDF] Sex-stratified genome-wide association and transcriptome-wide Mendelian randomization studies reveal drug targets of heart failure

Q Yang, Q Yang, X Wu, R Zheng, H Lin, S Wang… - Cell Reports …, 2024 - cell.com
The prevalence of heart failure (HF) subtypes, which are classified by left ventricular ejection
fraction (LVEF), demonstrate significant sex differences. Here, we perform sex-stratified …

Integrating urinary and plasma omics to identify markers and therapeutic targets for cardiac disease

SC de Ruiter, M van Vugt, C Finan, R Providencia… - medRxiv, 2024 - medrxiv.org
Introduction: Urinary metabolites, representing kidney regulated filtration of metabolism end
products, contain cardiac disease biomarkers such as NT-proBNP. We set out to integrate …

Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation

M van Vugt, C Finan, S Chopade, R Providencia… - medRxiv, 2023 - medrxiv.org
Background Altered metabolism plays a role in the pathophysiology of cardiac diseases,
such as atrial fibrillation (AF) and heart failure (HF). We aimed to identify novel plasma …

Large-scale Mendelian randomization identifies novel pathways as therapeutic targets for heart failure with reduced ejection fraction and with preserved ejection …

D Rasooly, C Giambartolomei, GM Peloso, H Dashti… - medRxiv, 2024 - medrxiv.org
We used expression quantitative trait loci (eQTLs) and protein quantitative trait loci (pQTLs)
to conduct genome-wide Mendelian randomization (MR) using 27,799 cases of heart failure …